Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CI NYSE:CNC NYSE:ELV NYSE:HUM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICigna Group$286.06-0.1%$276.63$239.51▼$338.89$75.67B0.31.73 million shs1.44 million shsCNCCentene$59.15+0.0%$43.06$25.08▼$60.76$29.21B1.067.41 million shs2.92 million shsELVElevance Health$394.41-0.1%$333.81$273.71▼$408.00$85.65B0.661.72 million shs1.09 million shsHUMHumana$307.79-0.1%$218.13$163.11▼$315.66$36.95B0.681.98 million shs677,907 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICigna Group0.00%+0.28%+3.85%+1.09%-9.58%CNCCentene0.00%+1.55%+41.34%+36.45%+4.83%ELVElevance Health0.00%+0.43%+14.44%+17.52%+5.93%HUMHumana0.00%+0.93%+42.99%+70.09%+36.91%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICigna Group$286.06-0.1%$276.63$239.51▼$338.89$75.67B0.31.73 million shs1.44 million shsCNCCentene$59.15+0.0%$43.06$25.08▼$60.76$29.21B1.067.41 million shs2.92 million shsELVElevance Health$394.41-0.1%$333.81$273.71▼$408.00$85.65B0.661.72 million shs1.09 million shsHUMHumana$307.79-0.1%$218.13$163.11▼$315.66$36.95B0.681.98 million shs677,907 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICigna Group0.00%+0.28%+3.85%+1.09%-9.58%CNCCentene0.00%+1.55%+41.34%+36.45%+4.83%ELVElevance Health0.00%+0.43%+14.44%+17.52%+5.93%HUMHumana0.00%+0.93%+42.99%+70.09%+36.91%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCICigna Group 2.81Moderate Buy$339.8018.79% UpsideCNCCentene 2.37Hold$56.94-3.73% DownsideELVElevance Health 2.61Moderate Buy$399.321.24% UpsideHUMHumana 2.18Hold$263.35-14.44% DownsideCurrent Analyst Ratings BreakdownLatest CI, ELV, HUM, and CNC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026HUMHumana UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$262.00 ➝ $320.005/22/2026CNCCentene UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$55.00 ➝ $61.005/22/2026ELVElevance Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$400.00 ➝ $460.005/22/2026CICigna Group UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$375.00 ➝ $400.005/21/2026CNCCentene Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$60.00 ➝ $72.005/20/2026HUMHumana Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral ➝ Overweight5/20/2026HUMHumana William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform5/20/2026HUMHumana Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy5/20/2026HUMHumana OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOutperform5/20/2026HUMHumana Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold5/20/2026HUMHumana Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Peer Perform(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCICigna Group$274.90B0.28$40.92 per share6.99$160.44 per share1.78CNCCentene$198.10B0.15$4.69 per share12.62$43.54 per share1.36ELVElevance Health$199.13B0.43$37.56 per share10.50$202.81 per share1.94HUMHumana$129.66B0.28$24.05 per share12.80$155.30 per share1.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCICigna Group$5.96B$23.5912.138.561.002.26%19.75%5.30%7/30/2026 (Estimated)CNCCentene-$6.67B-$13.14N/A13.411.14-3.25%5.57%1.54%7/28/2026 (Estimated)ELVElevance Health$5.66B$23.5116.7813.522.232.62%15.58%5.57%7/16/2026 (Estimated)HUMHumana$1.19B$9.3532.9220.662.860.82%10.45%3.75%7/29/2026 (Estimated)Latest CI, ELV, HUM, and CNC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2026Q1 2026CICigna Group$7.60$7.79+$0.19$6.26$66.29 billion$68.52 billion4/29/2026Q1 2026HUMHumana$9.97$10.31+$0.34$9.83$39.37 billion$39.65 billion4/28/2026Q1 2026CNCCentene$2.23$3.37+$1.14$3.11$47.53 billion$49.94 billion4/22/2026Q1 2026ELVElevance Health$10.74$12.58+$1.84$8.00$48.21 billion$49.49 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCICigna Group$6.242.18%+172.77%26.45%5 YearsCNCCenteneN/AN/AN/AN/AN/AELVElevance Health$6.881.74%+12.47%29.26%14 YearsHUMHumana$3.541.15%+7.20%37.86%N/ALatest CI, ELV, HUM, and CNC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/15/2026HUMHumanaquarterly$0.88501.79%6/26/20266/26/20267/31/20264/21/2026ELVElevance Healthquarterly$1.722.11%6/10/20266/10/20266/25/20264/22/2026CICigna Groupquarterly$1.562.27%6/4/20266/4/20266/18/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCICigna Group0.690.730.73CNCCentene0.761.121.12ELVElevance Health0.701.481.48HUMHumana0.661.771.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCICigna Group86.99%CNCCentene93.63%ELVElevance Health89.24%HUMHumana92.38%Insider OwnershipCompanyInsider OwnershipCICigna Group0.60%CNCCentene0.37%ELVElevance Health0.34%HUMHumana0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCICigna Group67,700264.53 million262.95 millionOptionableCNCCentene61,100493.80 million491.97 millionOptionableELVElevance Health97,100217.16 million216.42 millionOptionableHUMHumana67,060120.06 million119.82 millionOptionableCI, ELV, HUM, and CNC HeadlinesRecent News About These CompaniesHandelsbanken Fonder AB Has $3.24 Million Stock Position in Humana Inc. $HUMMay 24 at 4:57 AM | marketbeat.comABN Amro Investment Solutions Has $1.27 Million Stock Position in Humana Inc. $HUMMay 24 at 3:00 AM | marketbeat.comPNC Financial Services Group Inc. Decreases Stake in Humana Inc. $HUMMay 23 at 5:17 AM | marketbeat.comCongressional Joint Economic Committee Pegs Medicare Advantage Overpayments at $7 Billion Annually and RisingMay 22 at 1:30 PM | 247wallst.comPzena Investment Management LLC Purchases 41,125 Shares of Humana Inc. $HUMMay 22 at 6:53 AM | marketbeat.comNewport Trust Company LLC Decreases Position in Humana Inc. $HUMMay 22 at 6:34 AM | marketbeat.comHumana Sells Elderly Care Property to Cut Debt and Refocus CapitalMay 22 at 2:51 AM | tipranks.comHumana (HUM) Valuation Check As Barostim Medicare Advantage Coverage Expands For Heart Failure PatientsMay 22 at 1:50 AM | finance.yahoo.comHumana (HUM) is Rebounding to a Multi-Year Improvement in Margins and ReturnsMay 21, 2026 | insidermonkey.comDeutsche Bank upgrades Humana (HUM)May 21, 2026 | msn.comHumana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441May 20, 2026 | 247wallst.comNorth Dakota State Investment Board Makes New $1.52 Million Investment in Humana Inc. $HUMMay 20, 2026 | marketbeat.comBanque Cantonale Vaudoise Raises Holdings in Humana Inc. $HUMMay 20, 2026 | marketbeat.comHumana Establishes Pre-Capitalized Trusts for Contingent FundingMay 19, 2026 | tipranks.comHere's Why Investors Should Stay Neutral on Humana Stock for NowMay 19, 2026 | zacks.comPrior authorization rules vary widely among major commercial insurers, review findsMay 18, 2026 | medicalxpress.comMHumana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna?May 18, 2026 | 247wallst.comHumana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna?May 18, 2026 | 247wallst.comHumana: Perhaps The 'Buy The Dip' Thesis Was Right All Along (Rating Upgrade)May 18, 2026 | seekingalpha.comZacks Research Has Optimistic View of Humana FY2026 EarningsMay 18, 2026 | marketbeat.comCigna abandons pursuit of Humana, plans $10 billion share buybackMay 17, 2026 | zeebiz.comZNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?By Thomas Hughes | April 29, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 2026The $880M Bet to Survive Real Estate's ResetBy Jeffrey Neal Johnson | April 28, 2026Pipelines and Automation: 2 Energy Plays Built for Any Oil PriceBy Chris Markoch | April 26, 2026Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong MomentumBy Chris Markoch | May 10, 2026CI, ELV, HUM, and CNC Company DescriptionsCigna Group NYSE:CI$286.06 -0.18 (-0.06%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$285.25 -0.81 (-0.28%) As of 05/22/2026 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.Centene NYSE:CNC$59.15 +0.01 (+0.02%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$58.84 -0.31 (-0.52%) As of 05/22/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Elevance Health NYSE:ELV$394.41 -0.28 (-0.07%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$394.60 +0.19 (+0.05%) As of 05/22/2026 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.Humana NYSE:HUM$307.79 -0.16 (-0.05%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$302.93 -4.86 (-1.58%) As of 05/22/2026 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
